2025 annual financial data

MIRA Pharmaceuticals 2025 Financial results

Direct answer

Revenue was 0 USD.

Operating income was -10,493,112 USD and net income was -10,442,485 USD.
Operating cash flow was -4,661,669 USD.

Get free MIRA Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-10,493,112 USD
Net income
-10,442,485 USD
Operating cash flow
-4,661,669 USD